Showing results (151-160 of 170) with videos related to

Sort By:
Pageof 17
Oncotarget|February 14, 2018
A meta-analysis of the lymphatic microvessel density and survival in gastric cancer with 1809 casesLiang Liang, Wen-Ting Huang, Rong-Quan He, et al.
Cell Metabolism|April 3, 2024
A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axisYimin Dong, Honglei Kang, Renpeng Peng, et al.
International Journal of Oncology|April 23, 2020
Upregulated expression of SAC3D1 is associated with progression in gastric cancerAn-Gui Liu, Jin-Cai Zhong, Gang Chen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 2, 2022
Risk factors for polymyxin B-associated acute kidney injuryKang Chang, Haibo Wang, Jianping Zhao, et al.
Dose-Response : a Publication of International Hormesis Society|January 6, 2022
Active Enhancer Assessment by H3K27ac ChIP-seq Reveals Claudin-1 as a Biomarker for Radiation Resistance in Colorectal CancerZu-Xuan Chen, He-Qing Huang, Jia-Ying Wen, et al.
Iscience|December 24, 2025
Recurrence outcomes of robotic versus laparoscopic surgery for gastric cancer: A multicenter studyQing Zhong, Jun-Yu Chen, Meng-Qi Xue, et al.
Chest|May 16, 2026
Anti-C5a antibody STSA-1002 for patients with acute respiratory distress syndrome due to viral pneumonia: a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trialYeming Wang, Xiaobo Huang, Zhenshun Cheng, et al.
Biomedical and Environmental Sciences : BES|August 16, 2017
Genotypic Characterization of Methicillin-resistant Staphylococcus aureus Isolated from Pigs and Retail Foods in ChinaWei Wang, Feng Liu, Zulqarnain Baloch, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2022
An anti-CTLA-4 heavy chain-only antibody with enhanced T<sub>reg</sub> depletion shows excellent preclinical efficacy and safety profileXin Gan, Qianqian Shan, He Li, et al.
Frontiers in Medicine|June 27, 2022
Polymyxin B/Tigecycline Combination vs. Polymyxin B or Tigecycline Alone for the Treatment of Hospital-Acquired Pneumonia Caused by Carbapenem-Resistant <i>Enterobacteriaceae</i> or Carbapenem-Resistant <i>Acinetobacter baumannii</i>Kang Chang, Haibo Wang, Jianping Zhao, et al.
Pageof 17